New drug could reduce infusions for rare nerve disease

NCT ID NCT06537999

Recruiting now Disease control Sponsor: Dianthus Therapeutics Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 35 times

Summary

This study tests a new medicine called DNTH103 for adults with multifocal motor neuropathy (MMN), a rare nerve condition that causes muscle weakness. The goal is to see if the drug is safe and can help people go longer between their regular immunoglobulin treatments. About 36 adults aged 18 to 75 who currently need stable immunoglobulin therapy will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Study Site
RECRUITING

Scottsdale, Arizona, 85251, United States
Clinical Study Site
RECRUITING

Los Angeles, California, 90048, United States
Clinical Study Site
RECRUITING

Bradenton, Florida, 34205, United States
Clinical Study Site
RECRUITING

Tampa, Florida, 33620, United States
Clinical Study Site
RECRUITING

Honolulu, Hawaii, 96817, United States
Clinical Study Site
RECRUITING

Kansas City, Kansas, 66103, United States
Clinical Study Site
RECRUITING

Chapel Hill, North Carolina, 27599, United States
Clinical Study Site
RECRUITING

Cincinnati, Ohio, 45219, United States
Clinical Study Site
RECRUITING

Columbus, Ohio, 43210, United States
Clinical Study Site
RECRUITING

Houston, Texas, 77030, United States
Clinical Study Site
RECRUITING

Aarhus, 8200, Denmark
Clinical Study Site
RECRUITING

Copenhagen, 1172, Denmark
Clinical Study Site
RECRUITING

Marseille, 13005, France
Clinical Study Site
RECRUITING

Paris, 94000, France
Clinical Study Site
RECRUITING

Rome, 00189, Italy
Clinical Study Site
RECRUITING

Amsterdam, 1105, Netherlands
Clinical Study Site
RECRUITING

Utrecht, Netherlands
Clinical Study Site
RECRUITING

Skopje, North Macedonia
Clinical Study Site
RECRUITING

Bydgoszcz, 85-090, Poland
Clinical Study Site
RECRUITING

Katowice, 40-689, Poland
Clinical Study Site
RECRUITING

Krakow, 30-688, Poland
Clinical Study Site
RECRUITING

Krakow, 31-202, Poland
Clinical Study Site
RECRUITING

Belgrade, 11000, Serbia
Clinical Study Site
RECRUITING

Barcelona, 08035, Spain
Clinical Study Site
RECRUITING

London, England, United Kingdom
Clinical Study Site
RECRUITING

Oxford, England, United Kingdom

Conditions

Explore the condition pages connected to this study.

MULTIFOCAL MOTOR NEUROPATHY